Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 7Hot Flashes 6Breast Neoplasms 6Pain, Postoperative 4Prostatic Neoplasms 3Pain 3Vomiting 2Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Neuralgia 2Neoplasms 2Nausea 2Mucositis 2Anxiety Disorders 2Agnosia 2Acute Pain 2Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Rectal Neoplasms 1Psychotic Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Myalgia 1Lymphoma, Follicular 1Lung Neoplasms 1Laryngeal Diseases 1Ileus 1Glioblastoma 1

Interventions

Surveys and Questionnaires 3Testosterone 2Fatty Acids, Omega-3 2Exercise 2Educational Status 2Acupuncture Therapy 2methyl hydroxyethyl cellulose 1guizhi-shaoyao-zhimu decoction 1canakinumab 1Yoga 1Walking 1Vitamin B 12 1Therapeutics 1Occupational Therapy 1Letrozole 1Hyaluronic Acid 1Glucosamine 1Glucaric Acid 1Gabapentin 1Fish Oils 1Docosahexaenoic Acids 1Diphosphonates 1Diet Therapy 1Denosumab 1Curcumin 1Chondroitin Sulfates 1Chondroitin 1Cholecalciferol 1Cannabidiol 1Calcium Gluconate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Arthralgia × Gabapentin × Clear all
NCT03566394 2018-06-25

Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy

British Columbia Cancer Agency

Phase 2/3 Unknown
46 enrolled

Arthralgia, Myalgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡